Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
Abstract
Overweight and obesity is a global epidemic. Forecasting future trajectories of the epidemic is crucial for providing an evidence base for policy change. In this study, we examine the historical trends of the global, regional, and national prevalence of adult overweight and obesity from 1990 to 2021 and forecast the future trajectories to 2050.
Leveraging established methodology from the Global Burden of Diseases, Injuries, and Risk Factors Study, we estimated the prevalence of overweight and obesity among individuals aged 25 years and older by age and sex for 204 countries and territories from 1990 to 2050. Retrospective and current prevalence trends were derived based on both self-reported and measured anthropometric data extracted from 1350 unique sources, which include survey microdata and reports, as well as published literature. Specific adjustment was applied to correct for self-report bias. Spatiotemporal Gaussian process regression models were used to synthesise data, leveraging both spatial and temporal correlation in epidemiological trends, to optimise the comparability of results across time and geographies. To generate forecast estimates, we used forecasts of the Socio-demographic Index and temporal correlation patterns presented as annualised rate of change to inform future trajectories. We considered a reference scenario assuming the continuation of historical trends.
Citation impact
- FWCI
- 1117.18
- Percentile
- 100%
- References
- 98
Authors
1085Topics & keywords
- Overweight
- Obesity
- Environmental health
- Medicine
- Burden of disease
- Disease
- Global health
- Demography
Funding
- UDU.S. Department of Defense
- ADAmerican Diabetes Association
- BABill and Melinda Gates FoundationAward: OPP1152504
- AHAmerican Heart AssociationAward: R01DK125403
- AAmgen
- ELEli Lilly and CompanyAward: 2022-2024
- AAstraZeneca
- SSanofi
- WHWorld Health Organization
- AHAlberta Health Services
- KDKorean Diabetes Association
- DDanone
- JHJohns Hopkins University
- HRHospital Research Foundation
- IHInternational Headache Society
- WTWellcome TrustAwards: MR/R024227/1, R024227, 221854, MR/R024227, 221854/Z/20/Z, 350426, R01AG056477
- GPGuangdong Provincial Hospital of Traditional Chinese Medicine
- GOGovernment of Alberta
- ACAmarin Corporation
- CNChinese Nutrition Society
- NCNational Cerebral and Cardiovascular Center
- GOGovernment of Canada
- UOUniversity of Alberta
- NINational Institute for Health and Care ResearchAwards: 2022-2024, NIHR300175, R024227, 221854/Z/20/Z
- DODepartment of Health and Social Care
- CUCardiff University
- NRNational Research Foundation
- MOMinistry of Education, Culture, Sports, Science and TechnologyAwards: 24H00663, 2022-2024
- KSKing Saud UniversityAward: RSP-2025 R47
- MOMinistry of Education
- FCFondazione CariploAward: 2022-2024
- GDGeneralitat de Catalunya
- FWFonds Wetenschappelijk OnderzoekAward: 12ZU922N
- NRNational Research Foundation of KoreaAward: NRF-2023S1A3A2A05095298
- NNNovo Nordisk
- MPMinistarstvo Prosvete, Nauke i Tehnološkog RazvojaAwards: 2011-2023, 451-03-47/2023-01/200111, 451-03-47/, 175042, 451-03-47/2023-01
- MDMinistério da Ciência, Tecnologia e Ensino SuperiorAwards: 10.54499/UIDP/50006/2020, UIDP/50006, UIDP/50006/2020
- UDUniversidade do Porto
- VRVlaamse regering
- SOSwedish Orphan Biovitrum
- NONational Office for Philosophy and Social Sciences
- HLH. Lundbeck A/S
- RDRede de Química e TecnologiaAward: UIDP/50006/2020
- LALaboratório Associado para a Química VerdeAwards: 10.54499/UIDP/50006/2020, UIDP/50006/2020
- LDLilly Deutschland
- NSNational Science and Technology Council
- TDTour de Cure
- NINational Institutes of HealthAwards: R01AG056477, R01ES031391, R01DK125403, 2022-2024, K23HL161271, R024227
- AAllergan
- NPNovartis Pharma
- SGSanofi Genzyme
- NNNovo Nordisk Pharma
- CICanadian Institutes of Health Research
- MRMedical Research CouncilAwards: MR/R024227, R024227, MR/R024227/1, Y014154, R024227/1
- NHNational Health and Medical Research Council
- FPFundação para a Ciência e a TecnologiaAwards: 2023-2024, UIDP/50006/2020, UIDP/50006, DOI 10.54499, 10.54499/UIDP/50006/2020
- JSJapan Science and Technology AgencyAward: JPMJPR22R8
- ADAgència de Gestió d'Ajuts Universitaris i de Recerca
- DNDSM Nutritional Products
- NHNational Heart, Lung, and Blood InstituteAward: K23HL161271
- NINational Institute on Minority Health and Health Disparities
- PRPrecursory Research for Embryonic Science and TechnologyAward: JPMJPR22R8
- DSDaiichi Sankyo Europe
- CCilag